ADVERTISEMENT

Proton pump inhibitor use linked to lower risk for female cancers

Miriam Davis, PhD   |   Clinical Summary   |   05 January 2023
ADVERTISEMENT

Takeaway

  • Women using proton pump inhibitors (PPIs) may have reduced risk for female cancers, according to a 16-year population-based nationwide study from Taiwan.
  • The reduced risk was greatest for breast and ovarian cancers in 20- to 64-year-old women, and cervical and endometrial cancer in 40- to 64-year-old women.
  • No reduced risk was...

          

Topic Challenges

left
right